Kyla Comins

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

Joseph N Jarvis, David S. Lawrence, David B. Meya et al. · LSTM Online Archive (Liverpool School of Tropical Medicine) · 2022 · 219 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial

Kelly E. Dooley, Susan L. Rosenkranz, Francesca Conradie et al. · The Lancet Infectious Diseases · 2021 · 124 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease

Amita Gupta, Susan Swindells, Soyeon Kim et al. · Clinical Infectious Diseases · 2019 · 37 citations · Full text

Public Health, Health Sciences, Infectious Diseases +13

Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial

David S. Lawrence, Charles Muthoga, David B. Meya et al. · The Lancet Global Health · 2022 · 30 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study

Nishi Suryavanshi, Matthew Murrill, Amita Gupta et al. · Clinical Infectious Diseases · 2019 · 12 citations · Full text

Public Health, Health Sciences, Preventive Medicine +16